Roncoleukin, 1 mg/ml 1 ml 3 pcs

Interleukin-2 is produced by a subpopulation of T-lymphocytes (T-helper I ) in response to antigenic stimulation.

Indications

As part of the complex therapy in adults: common variable immunodeficiency;

Active ingredient

Interleukin 2

How to take, the dosage

Roncoleukin® is administered once daily by subcutaneous or intravenous drops of 0.5 – 1.0 mg at 1 – 3 day intervals, for a course of 1-3 injections. For intravenous administration the drug from the ampoule is transferred into 400 ml of isotonic sodium chloride solution for injection. Infusion of the entire solution volume is carried out by drip for 4-6 hours.

Interaction

Treatment with Roncoleukin® can be combined with treatment with all other medicines.

Special Instructions

If stored at 2 to 8°C, sodium lauryl sulfate crystals may precipitate and should dissolve at room temperature within 30 minutes.

Contraindications

Hypersensitivity to interleukin-2 or any drug component in anamnesis; allergy to yeast; pregnancy; autoimmune diseases, Stage III heart failure, Stage III pulmonary heart failure, metastatic brain lesion, terminal stage of renal cell cancer.

Side effects

In some cases during Roncoleukin® therapy short-term chills and fever may occur, which are treated with the usual therapeutic means and are not reasons for discontinuation of therapy.

Overdose

Manifestations of overdose were observed at a single dose of Roncoleukin® higher than 7 mg in the form of fever, cardiac arrhythmias, hypotension, dermatological allergic reactions.

Similarities

Roncoleukin-vet